Cargando…
Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study
BACKGROUND: Both positive and negative associations between higher body mass index (BMI) and Parkinson disease (PD) have been reported in observational studies, but it has been difficult to establish causality because of the possibility of residual confounding or reverse causation. To our knowledge,...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469450/ https://www.ncbi.nlm.nih.gov/pubmed/28609445 http://dx.doi.org/10.1371/journal.pmed.1002314 |
_version_ | 1783243576836096000 |
---|---|
author | Noyce, Alastair J. Kia, Demis A. Hemani, Gibran Nicolas, Aude Price, T. Ryan De Pablo-Fernandez, Eduardo Haycock, Philip C. Lewis, Patrick A. Foltynie, Thomas Davey Smith, George Schrag, Anette Lees, Andrew J. Hardy, John Singleton, Andrew Nalls, Mike A. Pearce, Neil Lawlor, Debbie A. Wood, Nicholas W. |
author_facet | Noyce, Alastair J. Kia, Demis A. Hemani, Gibran Nicolas, Aude Price, T. Ryan De Pablo-Fernandez, Eduardo Haycock, Philip C. Lewis, Patrick A. Foltynie, Thomas Davey Smith, George Schrag, Anette Lees, Andrew J. Hardy, John Singleton, Andrew Nalls, Mike A. Pearce, Neil Lawlor, Debbie A. Wood, Nicholas W. |
author_sort | Noyce, Alastair J. |
collection | PubMed |
description | BACKGROUND: Both positive and negative associations between higher body mass index (BMI) and Parkinson disease (PD) have been reported in observational studies, but it has been difficult to establish causality because of the possibility of residual confounding or reverse causation. To our knowledge, Mendelian randomisation (MR)—the use of genetic instrumental variables (IVs) to explore causal effects—has not previously been used to test the effect of BMI on PD. METHODS AND FINDINGS: Two-sample MR was undertaken using genome-wide association (GWA) study data. The associations between the genetic instruments and BMI were obtained from the GIANT consortium and consisted of the per-allele difference in mean BMI for 77 independent variants that reached genome-wide significance. The per-allele difference in log-odds of PD for each of these variants was estimated from a recent meta-analysis, which included 13,708 cases of PD and 95,282 controls. The inverse-variance weighted method was used to estimate a pooled odds ratio (OR) for the effect of a 5-kg/m(2) higher BMI on PD. Evidence of directional pleiotropy averaged across all variants was sought using MR–Egger regression. Frailty simulations were used to assess whether causal associations were affected by mortality selection. A combined genetic IV expected to confer a lifetime exposure of 5-kg/m(2) higher BMI was associated with a lower risk of PD (OR 0.82, 95% CI 0.69–0.98). MR–Egger regression gave similar results, suggesting that directional pleiotropy was unlikely to be biasing the result (intercept 0.002; p = 0.654). However, the apparent protective influence of higher BMI could be at least partially induced by survival bias in the PD GWA study, as demonstrated by frailty simulations. Other important limitations of this application of MR include the inability to analyse non-linear associations, to undertake subgroup analyses, and to gain mechanistic insights. CONCLUSIONS: In this large study using two-sample MR, we found that variants known to influence BMI had effects on PD in a manner consistent with higher BMI leading to lower risk of PD. The mechanism underlying this apparent protective effect warrants further study. |
format | Online Article Text |
id | pubmed-5469450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-54694502017-07-03 Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study Noyce, Alastair J. Kia, Demis A. Hemani, Gibran Nicolas, Aude Price, T. Ryan De Pablo-Fernandez, Eduardo Haycock, Philip C. Lewis, Patrick A. Foltynie, Thomas Davey Smith, George Schrag, Anette Lees, Andrew J. Hardy, John Singleton, Andrew Nalls, Mike A. Pearce, Neil Lawlor, Debbie A. Wood, Nicholas W. PLoS Med Research Article BACKGROUND: Both positive and negative associations between higher body mass index (BMI) and Parkinson disease (PD) have been reported in observational studies, but it has been difficult to establish causality because of the possibility of residual confounding or reverse causation. To our knowledge, Mendelian randomisation (MR)—the use of genetic instrumental variables (IVs) to explore causal effects—has not previously been used to test the effect of BMI on PD. METHODS AND FINDINGS: Two-sample MR was undertaken using genome-wide association (GWA) study data. The associations between the genetic instruments and BMI were obtained from the GIANT consortium and consisted of the per-allele difference in mean BMI for 77 independent variants that reached genome-wide significance. The per-allele difference in log-odds of PD for each of these variants was estimated from a recent meta-analysis, which included 13,708 cases of PD and 95,282 controls. The inverse-variance weighted method was used to estimate a pooled odds ratio (OR) for the effect of a 5-kg/m(2) higher BMI on PD. Evidence of directional pleiotropy averaged across all variants was sought using MR–Egger regression. Frailty simulations were used to assess whether causal associations were affected by mortality selection. A combined genetic IV expected to confer a lifetime exposure of 5-kg/m(2) higher BMI was associated with a lower risk of PD (OR 0.82, 95% CI 0.69–0.98). MR–Egger regression gave similar results, suggesting that directional pleiotropy was unlikely to be biasing the result (intercept 0.002; p = 0.654). However, the apparent protective influence of higher BMI could be at least partially induced by survival bias in the PD GWA study, as demonstrated by frailty simulations. Other important limitations of this application of MR include the inability to analyse non-linear associations, to undertake subgroup analyses, and to gain mechanistic insights. CONCLUSIONS: In this large study using two-sample MR, we found that variants known to influence BMI had effects on PD in a manner consistent with higher BMI leading to lower risk of PD. The mechanism underlying this apparent protective effect warrants further study. Public Library of Science 2017-06-13 /pmc/articles/PMC5469450/ /pubmed/28609445 http://dx.doi.org/10.1371/journal.pmed.1002314 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Noyce, Alastair J. Kia, Demis A. Hemani, Gibran Nicolas, Aude Price, T. Ryan De Pablo-Fernandez, Eduardo Haycock, Philip C. Lewis, Patrick A. Foltynie, Thomas Davey Smith, George Schrag, Anette Lees, Andrew J. Hardy, John Singleton, Andrew Nalls, Mike A. Pearce, Neil Lawlor, Debbie A. Wood, Nicholas W. Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study |
title | Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study |
title_full | Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study |
title_fullStr | Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study |
title_full_unstemmed | Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study |
title_short | Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study |
title_sort | estimating the causal influence of body mass index on risk of parkinson disease: a mendelian randomisation study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469450/ https://www.ncbi.nlm.nih.gov/pubmed/28609445 http://dx.doi.org/10.1371/journal.pmed.1002314 |
work_keys_str_mv | AT noycealastairj estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy AT kiademisa estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy AT hemanigibran estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy AT nicolasaude estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy AT pricetryan estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy AT depablofernandezeduardo estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy AT haycockphilipc estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy AT lewispatricka estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy AT foltyniethomas estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy AT daveysmithgeorge estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy AT estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy AT schraganette estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy AT leesandrewj estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy AT hardyjohn estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy AT singletonandrew estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy AT nallsmikea estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy AT pearceneil estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy AT lawlordebbiea estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy AT woodnicholasw estimatingthecausalinfluenceofbodymassindexonriskofparkinsondiseaseamendelianrandomisationstudy |